March 2015 FDA Recall Drug by Mylan Institutional Llc
D-1328-2015 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Mylan Institutional Llc on March 18, 2015 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1328-2015

Reason for Recall
Presence of Particulate Matter
Initiated
03-18-2015
Reported
08-19-2015
Quantity
a) 15,095 vials b) 300 vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Mylan Institutional LLC
Nationwide and Puerto Rico
Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-467-99.

Batch or Lot Expiration Information

Lot# : a) 7801082, Exp. 07/15 and b) 7801421, Exp. 09/16